Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2000
10/25/2000EP1045921A2 Feline immunodeficiency virus gene therapy vectors
10/25/2000EP1045920A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy
10/25/2000EP1045919A1 Novel promoter elements for persistent gene expression
10/25/2000EP1045918A1 G protein-related kinase mutants in essential hypertension
10/25/2000EP1045917A2 Method for reduction of transgene copy number
10/25/2000EP1045916A1 Enzymatic conversion of gdp-mannose to gdp-fucose
10/25/2000EP1045915A2 Regulation of biological events using multimeric chimeric proteins
10/25/2000EP1045914A1 Testis-specific human svph1-8 proteinase
10/25/2000EP1045913A2 Human protease molecules
10/25/2000EP1045912A1 Polyketides and their synthesis
10/25/2000EP1045911A1 Novel nucleic acid sequence encoding flp recombinase
10/25/2000EP1045910A1 Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease
10/25/2000EP1045909A1 Hm2 cDNA RELATED POLYPEPTIDES AND METHODS OF USE
10/25/2000EP1045908A2 Human urotensin ii
10/25/2000EP1045907A1 Dkr polypeptides
10/25/2000EP1045906A1 Apo-2 ligand
10/25/2000EP1045905A2 Il-17rh dna and polypeptides
10/25/2000EP1045904A1 Fatty acid transport proteins
10/25/2000EP1045903A1 Nucleic acids encoding a functional human purinoreceptor p2x3 and methods of production and use thereof
10/25/2000EP1045902A1 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME
10/25/2000EP1045901A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4
10/25/2000EP1045900A2 Mammalian alpha helical protein-1
10/25/2000EP1045899A2 Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host
10/25/2000EP1045862A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation
10/25/2000EP1045859A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS)
10/25/2000EP1045857A1 MULTIPLE DRUG RESISTANCE GENE atrC OF ASPERGILLUS NIDULANS
10/25/2000EP1045703A1 Stabilization of lipid:dna formulations during nebulization
10/25/2000EP1045702A1 Methods of controlling cell differentiation and growth using a fusion protein and a drug
10/25/2000EP1045697A2 Extension of cellular lifespan, methods and reagents
10/25/2000EP1045642A1 Animal nutrition compositions
10/25/2000EP1045635A1 Cloning using donor nuclei from differentiated fetal and adult cells
10/25/2000EP1045632A1 A STARCHLESS VARIETY OF $i(PISUM SATIVUM) HAVING ELEVATED LEVELS OF SUCROSE
10/25/2000EP1045631A1 Plant senescence-associated genes
10/25/2000EP0750626B1 Corpuscles of stannius protein, stanniocalcin
10/25/2000EP0674711A4 Developmental regulation in anther tissue of plants
10/25/2000CN1271391A Methods and compositions for therapies using genges encoding secreted proteins such as interferon-beta
10/25/2000CN1271390A Gene
10/25/2000CN1271389A Nucleic acid vaccines encoding G protein of respiratory syncytial virus
10/25/2000CN1271388A Seed plants characterized by delayed seed dispersal
10/25/2000CN1271387A Mammalian cytokine: interleukin-B30 and related reagents
10/25/2000CN1271386A Amino-terminally trancated RANTES as chemokine antagonists
10/25/2000CN1271385A Amino-terminally truncated MCP-2 as chemokine antagnosits
10/25/2000CN1271384A Method for influencing the P53 linkage in target genes
10/25/2000CN1271383A Animal feed with low phytic acid, oil burdened and protein laden grain
10/25/2000CN1271382A Microbial agricultural chemical
10/25/2000CN1271364A Isolated proteins having retinol dehydrogenase activity and which associate with retinol binding protein receptors
10/25/2000CN1271020A Effective test HIV-1 and HIV-2 oligonucleotide reverse transcirpt initiator and its using method
10/25/2000CN1271019A Increasing specificity of nuclein acid expansion by carrier nucleic acid
10/25/2000CN1271018A Process for producing L-glutamic acid
10/25/2000CN1271017A Process for producing xylitol
10/25/2000CN1271015A Whole-length gene sequence of donkey leucocytic hyptoxic vaccine strain for horse's infectious anemia (EIAV)
10/25/2000CN1271014A Human cholesterol ester synthtase-1 gene promoter 1
10/25/2000CN1271013A Human cholesterol ester synthetase-1 gene promoter 7
10/25/2000CN1271012A New human cation transfer related protein and its code sequence
10/25/2000CN1271011A New human phosphoric triesterase related protein and its code sequence
10/25/2000CN1271010A New human aromatic esterase protein and its code sequence
10/25/2000CN1271009A New human diacyl glyceropyrophosphate phosphatase protein and its code sequence
10/25/2000CN1271008A New human salt-resisting protein subunit protein and its code sequence
10/25/2000CN1271007A New human chitinase protein and its code sequence
10/25/2000CN1271006A New human proteinase subunit protein and its code sequence
10/25/2000CN1271005A New human cytochrome protein and its code sequence
10/25/2000CN1270962A Improved method for preparing DNA from blooc serum and plasma
10/25/2000CN1057775C Anti-thrombus active peptide and preparation method thereof
10/25/2000CN1057774C 乙型肝炎疫苗 Hepatitis B Vaccine
10/24/2000US6138077 Method, apparatus and computer program product for determining a set of non-hybridizing oligonucleotides
10/24/2000US6137033 Nucleotide sequence which codes an insecticidal polypeptide; for the induction of apoptosis and use as a pesticides
10/24/2000US6137032 Xylanase obtained from an anaerobic fungus
10/24/2000US6137031 Nucleic acid construct coding a transcription factor associated with prevention of infection by microorganism; microbicides
10/24/2000US6137030 Nucleotide sequence coding a pokeweed antiviral protein mutant with reduced phytotoxicity; for preventing viral and fungal infection
10/24/2000US6137029 Chimeric gene formed by fusion of the promoter of pepck (p-enolpyruvate carboxyquinase) to the structural gene of human insulin; allows physiologically regulated production of human insulin, in a tissue different from the pancreas
10/24/2000US6136965 Deoxynucleic alkyl and alkoxy thiourea compounds
10/24/2000US6136964 Nucleic acid sequences encoding the lysophosphatidic acid acyltransferase (lpaat); use to screen for enzyme inhibitors of lpaat
10/24/2000US6136963 Parasitic helminth DiAg2 nucleic acid molecules, and uses thereof
10/24/2000US6136962 Covalent attachment of unmodified nucleic acids to silanized solid phase surfaces
10/24/2000US6136958 Immunoglobulins which bind preferential mammalian polypeptide; for the treatment of cancer; anticarcinogenic agents
10/24/2000US6136957 Antibodies which bind granulocyte-macrophane colony-stimulating factor receptor
10/24/2000US6136955 Mammalian polypeptide associated with spindle and centromers; for the diagnosis, prevention and treatment of cell proliferation defects
10/24/2000US6136954 Polypeptide which activates transcription in eucaryotic cells in the presence of antibiotic; for analysis of cellular proteins
10/24/2000US6136953 Human antiproliferative polypeptide for the detection of vascular injuries
10/24/2000US6136792 Prostate specific enhancer polynucleotides and methods of use thereof
10/24/2000US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors
10/24/2000US6136779 Methods of specifically transcriptionally modulating the expression of gene of interest
10/24/2000US6136605 Glutathione S-transferase isoforms
10/24/2000US6136604 Oligonucleotides which target preferential nucleotide sequences for the suppression on expression of human enzyme; for treatment of skin disorders; anticarcinogenic agents; antiinflammatory agents
10/24/2000US6136603 Oligonucleotides which target the untranslated region of a cytokine receptor gene; for treatment of eosinophil defects such as asthma, rhinitis and dermatitis; wound healing agents; antiinflammatory agents; anticarcinogenic agents
10/24/2000US6136602 Nucleotide sequences which can hybridize to preferential target nucleic acids; for the suppression of the expression of genes associated with antibiotic resistance and the prevention of bacterial infections
10/24/2000US6136599 Human hybrid host cell for mammalian gene expression
10/24/2000US6136597 Nucleotide sequences comprising regulatory sequences for the efficient transferring of nucleic acid sequences to cytoplasm and expression of heterologous nucleic acids
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136594 Expression plasmid with defects in gene associated with propagation but which codes cystic fibrosis transmembrane conductance regulator; for gene therapy
10/24/2000US6136588 Nucleotide sequences coding a bacterial enzymatic protein for biodegradation
10/24/2000US6136585 Attenuation of negative stranded RNA viruses by rearrangement of genes and uses thereof
10/24/2000US6136584 Joining polypeptide; for the development of and screening of therapy agents for autoimmune diseases
10/24/2000US6136583 Amidase
10/24/2000US6136581 Kinase genes and uses
10/24/2000US6136579 Isolating enzymatic protein; infecting a cell culture with pox viral vector, recovering enzymatic protein from lysis products
10/24/2000US6136576 Method for the recombinant production of 1,3-propanediol
10/24/2000US6136574 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/24/2000US6136572 Recombinant KAT enzyme and process for its preparation
10/24/2000US6136570 Method for producing RNA viruses from cDNA
1 ... 3166 3167 3168 3169 3170 3171 3172 3173 3174 3175 3176 3177 3178 3179 3180 3181 3182 3183 3184 3185 3186 ... 4023